Related Experiment Video

Updated: Aug 20, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

A pharmacological approach for the selection of potential anticancer agents

John A Double1

  • 1Cancer Research Unit, University of Bradford, Bradford, Yorkshire BD7 1DP, UK. j.a.double@bradford.ac.uk

Alternatives to Laboratory Animals : ATLA
|December 17, 2004
PubMed

Insights

Developing new anticancer agents is becoming more rational through pharmacological approaches. A novel hollow fibre system significantly reduces animal usage while yielding meaningful antitumour data.

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Development

Background:

  • Anticancer agent development historically relied on empirical methods.
  • Advancements in understanding cancer molecular processes enable a more rational drug development approach.
  • Current research focuses on reducing animal testing in preclinical studies.

Purpose of the Study:

  • To evaluate a pharmacological approach for selecting anticancer agents.
  • To assess the utility of the hollow fibre system in generating antitumour data.
  • To determine the potential of the hollow fibre system for reducing and refining animal usage in cancer research.

Main Methods:

  • A pharmacological approach was used to select potential anticancer agents.
  • The hollow fibre system was employed, involving tumor cells cultured in biocompatible fibers implanted in mice.
  • Pharmacodynamic endpoints were utilized to analyze antitumour data.

Main Results:

  • A pharmacological approach yielded meaningful antitumour data.
  • The hollow fibre system produced meaningful antitumour data with pharmacodynamic endpoints.
  • An 80% reduction in animal usage was achieved through this pharmacological approach.

Conclusions:

  • The hollow fibre system offers a method to obtain significant antitumour data with reduced animal use.
  • This system increases data acquisition per animal and may eliminate the need for untreated control groups.
  • The hollow fibre system represents a significant advancement in the reduction and refinement of animal testing in anticancer drug development.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...